Year : 2019 | Volume
: 30 | Issue : 6 | Page : 243-
Advancement of urological oncology and more
Stephen Shei-Dei Yang
Department of Urology, Taipei Tzu Chi Hospital, New Taipei; School of Medicine, Buddhist Tzu Chi University, Hualien, Taiwan
Dr. Stephen Shei-Dei Yang
Department of Urology, Taipei Tzu Chi Hospital and Buddhist Tzu Chi University, New Taipei City
|How to cite this article:|
Yang SS. Advancement of urological oncology and more.Urol Sci 2019;30:243-243
|How to cite this URL:|
Yang SS. Advancement of urological oncology and more. Urol Sci [serial online] 2019 [cited 2020 Sep 20 ];30:243-243
Available from: http://www.e-urol-sci.com/text.asp?2019/30/6/243/273888
One of the big issues in surgical oncology is “How safe could open extravesical bladder cuff resection (BCR) guarantee complete removal of ipsilateral ureteral orifice?” Lin et al. reported their experience and concluded that open extravesical BCR does not guarantee the complete removal of ipsilateral ureteral orifice. Increased risk of superficial intravesical recurrence is noted in patients with residual ureteral orifice. Such warning is also true to laparoscopic BCR!!
Is “smaller prostate volume is associated with adverse pathological features and biochemical recurrence after radical prostatectomy?” The answer was “Yes” by Blue et al. Prostate volume should be considered as a prognostic feature when counseling patients with both elevated prostate-specific antigen and newly diagnosed prostate cancer.
Knowing these virulence genes' variation may help control multiple drug-resistant urinary tract infection (UTI) in future. Muraleetharan et al. investigated “Genotyping and molecular characterization of extended-spectrum beta-lactamases producing uropathogenic Escherichia coli.” Hope that early genotyping may help selecting appropriate antibiotics to control febrile UTI.
More issues dealing with detrusor underactivity, large renal stones, and pediatric pyeloplasty may help your daily practice!